Acupressure for Cough in Lung Cancer Survivors

The goal of this randomized controlled trial is to examine the effect of an acupressure intervention in alleviating cough and reducing co-occurring symptoms (dyspnea, cough, and fatigue) in patients with lung cancer. The hypotheses are: 1. Acupressure can alleviate cough in lung cancer survivors; 2. Acupressure can reduce a cough-related symptom cluster (dyspnea-cough-fatigue) experienced by lung cancer survivors; 3. Acupressure can reduce the symptom burden and improve the health-related quality of life and functional capacity of lung cancer survivors experiencing cough. Participants will: Receive acupressure for 8 weeks or receive an education booklet; Keep a diary of their acupressure practice and symptoms; Be assessed at baseline (T0), early intervention (T1), post-intervention (T2), and 8 weeks after the intervention period (T3).

NCT Number	NCT07315672
Lead Sponsor	The University of Hong Kong Collaborators: The University of Hong Kong-Shenzhen Hospital, Queen Mary Hospital, Hong Kong
Conditions	Lung Cancer (Diagnosis), Acupressure, Coughing, Symptom Cluster
Enrollment	80 participants
Start Date	2026-03-09
Primary Completion	2026-12 (estimated)
Study Completion	2027-02 (estimated)
Updated on ClinicalTrials.gov	2026-08-11